CompaniesByCap
TVTX
Travere Therapeutics Inc. (TVTX)
NASDAQ · Healthcare

Travere Therapeutics Inc. Cash Flow 2011–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2013Dec 2012Feb 2012Feb 2011
Operating Activities
Operating Cash Flow37.8M-237.5M-280.0M-186.3M-14.8M-42.7M-58.2M-25.0M7.4M-3.4M-1.4M-17.6M-2.7M-49-689
Depreciation & Amort.
Investing Activities
Capital Expenditure668,000191,0005.1M6.8M195,000727,000887,0001.4M22,000117,00024,774
Free Cash Flow-280.7M-186.5M-19.9M-49.5M-58.4M-25.7M6.5M-4.9M-1.4M-17.7M-2.8M
Financing Activities
Dividends Paid
Stock Buybacks00958,000

Travere Therapeutics Inc. Cash Flow — FAQ

Travere Therapeutics Inc. (TVTX) cash flow over the last 12 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see TVTX's cash flow history?

The chart and table above show Travere Therapeutics Inc.'s cash flow by year and by quarter, including the growth rate.